Italia markets closed

MEI Pharma, Inc. (0JW9.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,2328-0,5387 (-14,28%)
Alla chiusura: 06:27PM BST
Schermo intero
Caricamento grafico interattivo in corso...
  • GlobeNewswire

    Anson and Cable Car File Preliminary Consent Materials to Remove Entire Board of Directors at MEI Pharma, Inc.

    Believe the Board Needs to be Held Accountable for its Poor Judgment and Value-Destructive Initiatives Reiterate their Concern that the Board is Not Acting in the Best Interest of Stockholders Believe Immediate Action Must be Taken to Prevent the Further Destruction of Value TORONTO and SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) -- Anson Funds (“Anson”) and Cable Car Capital LLC (“Cable Car” and, together with Anson, “we” or “us”), which collectively beneficially own approximately 14.8% of th

  • GlobeNewswire

    Anson Funds and Cable Car Capital Issue Statement Regarding the Inferior Proposed Transaction between MEI Pharma and Infinity Pharmaceuticals

    Emphasizes the Board’s Failure to Adequately Consider the Superior Acquisition Proposal Presented by Anson Funds and Cable Car Capital Believes the Misguided Transaction with Infinity Pharmaceuticals Will Continue to Destroy Stockholder Value Have Voted Against the Proposed Combination ahead of the Upcoming Special Meeting Scheduled for July 14, 2023 TORONTO and SAN FRANCISCO, June 27, 2023 (GLOBE NEWSWIRE) -- Anson Funds (“Anson”) and Cable Car Capital LLC (“Cable Car” and, together with Anson,

  • GlobeNewswire

    Anson Funds and Cable Car Capital Issue Statement Regarding MEI Pharma’s Rejection of Their Acquisition Proposal

    TORONTO and SAN FRANCISCO, June 01, 2023 (GLOBE NEWSWIRE) -- Anson Funds (“Anson”) and Cable Car Capital LLC (“Cable Car” and, together with Anson, “we” or “us”), which collectively beneficially own approximately 14.8% of the outstanding common stock of MEI Pharma, Inc. (the “Company” or “MEIP”; NasdaqCM: MEIP), today issued the following statement in response to the rejection by the Company’s board of directors (the “Board”) of our proposal to acquire all outstanding shares of MEIP not already